Nightingale Health Oyj

HEL-HEALTH
Nasdaq Helsinki NYSE
Healthcare Health Information Services
Global Rank
#20324
Country Rank
n/a
Market Cap
186.55 M
Price
3.02
Change (%)
1.86%
Volume
33,184

Nightingale Health Oyj's latest marketcap:

186.55 M

As of 06/05/2025, Nightingale Health Oyj's market capitalization has reached $186.55 M. According to our data, Nightingale Health Oyj is the 20324th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 186.55 M
Revenue (ttm) 5.67 M
Net Income (ttm) -19,618,835.04
Shares Out 60.35 M
EPS (ttm) -0.33
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 06/04/2025
Market Cap Chart
Data Updated: 06/05/2025

Nightingale Health Oyj's yearly market capitalization.

Nightingale Health Oyj has seen its market value drop from €221.68 M to €162.95 M since 2021, representing a total decrease of 26.49% and an annual compound decline rate (CAGR) of 8.58%.
Date Market Cap Change (%)
06/05/2025 €162.95 M -4.16%
12/30/2024 €173.79 M 158.08%
12/29/2023 €67.34 M 9.84%
12/30/2022 €61.31 M -72.34%
12/30/2021 €221.68 M

Company Profile

About Nightingale Health Oyj

Nightingale Health Oyj is a pioneering health technology company specializing in advanced health data platforms designed to detect disease risks. Operating in Finland, the United Kingdom, Europe, the United States, and internationally, the company leverages innovative solutions to improve preventive healthcare.

Key Offerings

  • Health Check: A comprehensive service that identifies risks for common chronic diseases using just a single blood sample.
  • Health Check Remote: Enables remote health assessments for greater accessibility.
  • Diagnostic Services: Includes blood analysis, self-collection kits, urine analysis, and biomarker profiling.

Partnerships & Clients

Nightingale Health Oyj collaborates with research programs, universities, and healthcare providers to deliver its cutting-edge services. The company has also entered into a research collaboration agreement with ZOE Limited to enhance its blood collection technology.

Company Background

Founded in 2002, Nightingale Health Oyj is headquartered in Helsinki, Finland, and continues to lead advancements in predictive health analytics.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.